Jacqui Clarke
Follow
Get notifications in MyBN when activity occurs.
Jacqui Clarke
Alternate Director for Paul Fudge / Empire Energy Group
Jacqui Clarke has over 30 years of experience in professional practice with the Big 4, including more than 16 years as a partner of Deloitte.
Ms Clarke advises a broad range of groups including private family groups, entrepreneurial growth companies and not-for-profit organisations. Her experience extends across Australia, NZ, China and Singapore; and covers many industries and sectors including property, professional services, technology, agriculture, oil and gas.
Ms Clarke is a Chartered Accountant, Chartered Tax Advisor and Justice of the Peace. She is also a Fellow of the Institute of Chartered Accountants, and a graduate of the Australian Institute of Company Directors.
Ms Clarke advises a broad range of groups including private family groups, entrepreneurial growth companies and not-for-profit organisations. Her experience extends across Australia, NZ, China and Singapore; and covers many industries and sectors including property, professional services, technology, agriculture, oil and gas.
Ms Clarke is a Chartered Accountant, Chartered Tax Advisor and Justice of the Peace. She is also a Fellow of the Institute of Chartered Accountants, and a graduate of the Australian Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 92nd | Empire Energy Group | 100% | 15% |
| 1594th | Actinogen Medical | -59% | -9% |
| 1644th | Chimeric Therapeutics | -62% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 743rd |  | Empire Energy Group | $14.0m |
| 863rd | | Future First Technologies | $4.9m |
| 864th | | Chimeric Therapeutics | $4.9m |
| 866th |  | DGO Gold | $4.8m |
| 867th | | Actinogen Medical | $4.8m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, BKI Investment Company | 24 Jan 2022 |
| NEW ROLE: Alternate Director for Paul Fudge, Empire Energy Group | 30 Aug 2021 |
